Motexafin gadolinium induces mitochondrially-mediated caspase-dependent apoptosis
1Pharmacyclics Inc., 995 Arques Ave., Sunnyvale, CA 94085, USA.
Abstract:
Motexafin gadolinium (MGd, Xcytrin) is a tumor-localizing redox mediator that catalyzes the oxidation of intracellular reducing molecules including NADPH, ascorbate, protein and non-protein thiols, generating reactive oxygen species (ROS). MGd localizes to tumors and cooperates with radiation and chemotherapy to kill tumor cells in tissue culture and animal models. In this report, we demonstrate that MGd triggers the mitochondrial apoptotic pathway in the HF-1 lymphoma cell line as determined by loss of mitochondrial membrane potential, release of cytochrome c from mitochondria, activation of caspase-9 prior to caspase-8, cleavage of PARP and annexin V binding. There was minimal effect on MGd-induced apoptosis by the caspase inhibitor z-VAD-fmk, even though caspase-3 activity (as measured by DEVD-cleavage) was completely inhibited. However, MGd-induced apoptosis was reduced to baseline levels by the more potent caspase inhibitor Q-VD-OPh, demonstrating that MGd-induced apoptosis is indeed caspase-dependent. Apoptosis induced by dexamethasone, doxorubicin and etoposide (mediated through the mitochondrial pathway) was also more sensitive to inhibition by Q-VD-OPh than z-VAD-fmk. Our results demonstrating differential sensitivity of drug-induced apoptosis to caspase inhibitors suggest that the term "caspase-independent apoptosis" cannot be solely defined as apoptosis that is not inhibited by z-VAD-fmk as has been utilized in some published studies.
Insights
Motexafin gadolinium (MGd) triggers apoptosis in lymphoma cells by generating reactive oxygen species (ROS) and activating the mitochondrial pathway. This process is caspase-dependent, challenging previous definitions of caspase-independent apoptosis.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Pathways
Background:
- Motexafin gadolinium (MGd) is a redox mediator that localizes to tumors and generates reactive oxygen species (ROS).
- MGd enhances the efficacy of radiation and chemotherapy in preclinical models.
- Understanding the precise cell death mechanisms induced by MGd is crucial for its clinical application.
Purpose of the Study:
- To elucidate the specific apoptotic pathway triggered by Motexafin gadolinium (MGd) in the HF-1 lymphoma cell line.
- To investigate the role of caspases in MGd-induced apoptosis.
- To re-evaluate the definition of caspase-independent apoptosis based on inhibitor sensitivity.
Main Methods:
- Assessed mitochondrial apoptotic pathway markers: mitochondrial membrane potential, cytochrome c release, caspase activation (caspase-9, caspase-8, caspase-3), PARP cleavage, and annexin V binding.
- Utilized specific caspase inhibitors: z-VAD-fmk (pan-caspase inhibitor) and Q-VD-OPh (potent pan-caspase inhibitor).
- Compared MGd-induced apoptosis sensitivity to known mitochondrial pathway inducers (dexamethasone, doxorubicin, etoposide) using caspase inhibitors.
Main Results:
- MGd induced apoptosis via the mitochondrial pathway, evidenced by loss of mitochondrial membrane potential, cytochrome c release, caspase-9 activation preceding caspase-8, PARP cleavage, and annexin V binding.
- MGd-induced apoptosis was significantly inhibited by the potent caspase inhibitor Q-VD-OPh, confirming caspase dependence.
- Minimal inhibition was observed with z-VAD-fmk, highlighting differential caspase inhibitor efficacy and suggesting limitations in defining apoptosis solely by z-VAD-fmk resistance.
Conclusions:
- Motexafin gadolinium (MGd) triggers apoptosis through the mitochondrial pathway in HF-1 lymphoma cells.
- MGd-induced apoptosis is caspase-dependent, contrary to potential interpretations based on z-VAD-fmk insensitivity.
- The study suggests that the definition of 'caspase-independent apoptosis' requires refinement, as it cannot be solely based on resistance to z-VAD-fmk.
Related Concept Videos
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy


